Clean Science & Technology Ltd. · NSE:CLEAN
Clean Science & Technology — Q2 FY2024 Earnings Presentation
21 slides from Clean Science & Technology's earnings presentation, Nov 2, 2023
Slide 1: Stock exchange cover letter for investor presentation
02.11.2023 To, BSE Limited National Stock Exchange of India Limited Phiroze JeeJeebhoy Towers, Exchange Plaza, Plot no. C/1, Dalal Street, G Block, Bandra-Kurla Complex Fort, Mumbai – 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543318 Trading Symbol: CLEAN Subject: Investor Presentation. Dear S
Slide 2: Clean Science and Technology Ltd. Investor Presentation Q2 FY2024
Clean Science and Technology Ltd. Investor Presentation Q2 FY 2024 I NOVEMBER 2023
Slide 3: Safe Harbour
I SAFE HARBOUR This investor presentation has been prepared by Clean Science and Technology Limited (“CSTL”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered
Slide 4: Q2 FY2024 & H1 FY2024 Update
Q2 FY 2024 & H1 FY2024 Update
Slide 5: Q2 FY24 Update
I Q2 FY24 UPDATE Lower realization impacted the revenue growth; EBITDA margins improved further 181 205 234 248 237 217 188 Revenue in INR Crore 181 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY24 49.1% 46.1% 42.7% 41.3% 41.3% 42.4% 39.4% 39.8% 29.9% 39.2% 35.1% 37.9% 35.5% 33.1% 34.
Slide 6: Q2 FY24 and H1 FY24 P&L Overview - Standalone
I Q2 FY24 and H1 FY24 P&L OVERVIEW - STANDALONE Moderation in raw material prices and improved profit contribution from relatively newer products led to higher EBITDA margin during the quarter P&L (INR Crore) Q2 FY2024 Q1 FY2024 Q-o-Q (%) Q2 FY2023 Y-o-Y (%) H1 FY 2024 H1 FY 2023 Y-o-Y (%) Sale of p
Slide 7: H1 FY2024: Debt Free Balance Sheet with Cash Surplus
I H1 FY 2024: DEBT FREE BALANCE SHEET WITH CASH SURPLUS OF ~INR 250 CRORES Growth capex being funded from internal accruals In INR Crore As at As at 30-Sept.-2023 31-March-2023 Assets Non-current assets Fixed Assets 413.6 422.1 Capital work-in-progress 2.2 4.1 Right of use asset 3.8 3.9 Other non-cu
Slide 8: Revenue Profile – H1 FY2024
I REVENUE PROFILE – H1 FY 2024 Revenue contribution from domestic market increased REVENUE MIX BY SEGMENT REVENUE MIX BY GEOGRAPHY 14% 11% 6% 10% 29% 20% 36% 19% H1 FY24 21% H1 FY23 H1 FY24 35% H1 FY23 67% 68% 15% 15% 19% 15% Performance chemicals --- Pharma & Agro Intermediates FMCG chemicals China
Slide 9: Corporate presentation
Corporate presentation
Slide 10: Clean Science and Technology at a Glance
I CLEAN SCIENCE AND TECHNOLOGY AT A GLANCE A brief Introduction about the Company ➢ One of the fastest growing and among the most profitable fine and specialty chemical companies globally. Among the largest manufacturers of certain specialty chemicals developed in-house. ➢ Among the few global organ
Slide 11: Company Evolution
I COMPANY EVOLUTION Continuous R&D and Innovation has led to new product launches on a consistent basis YEAR 2006 2009 2011 2014 2018 2020 2021 2022 2023 REVENUES (INR Crore) - 1 19 120 241 419 512 685 936 ➢ Commercialized plant to 2022 2023 manufacture P-BQ and TBHQ ➢ Commercialized unique 2020 ➢ C
Slide 12: Diversified Product Profile Serving Critical End-User Industries
I DIVERSIFIED PRODUCT PROFILE SERVING CRITICAL END-USER INDUSTRIES Largest capacity in the world for our flagship products PERFORMANCE PHARMA AND AGRO FMCG CHEMICALS INTERMEDIATES CHEMICALS MEHQ (Monomethyl Ether of Hydroquinone) Guaiacol 4-MAP (4-Methoxy Acetophenone) ➢ Used as polymerization inhib
Slide 13: Key Differentiators That Add Value
I KEY DIFFERENTIATORS THAT ADD VALUE Unique benefits that set our business apart from competition INNOVATION GLOBAL LEADERS PREFERRED PARTNER STATE-OF-THE-ART Strategic process innovation Among the largest OF CHOICE Multiple, automated and new product producers globally of Strong and long term manuf
Slide 14: Steadfast Focus on Research & Development
I STEADFAST FOCUS ON RESEARCH & DEVELOPMENT Pioneered commercialization of catalytic reactions Research and Development team’s focus areas Enhance our existing catalyst Develop products with high demand D 1 systems to further optimize yield and selectivity D 2 Expand product portfolio in the perform
Slide 15: Cohesive and Technocrat Promoters
I COHESIVE AND TECHNOCRAT PROMOTERS Strong visibility on longevity of Promoters’ engagement in the business Over 27 years of work experience in Over 17 years of experience in the the chemical industry. chemical industry. Previously worked as an Executive Director at Mangalam Drugs and Bachelor of Ch
Slide 16: Robust Corporate Governance
I ROBUST CORPORATE GOVERNANCE Distinguished Board of Directors and reputed financial market participants underscore sound governance PROFILE OF NON-EXECUTIVE, INDEPENDENT DIRECTORS ON THE BOARD PRADEEP RATHI PROF. G. D. YADAV Sanjay Kothari Chairman and Non-Executive Director Non-Executive, Independ
Slide 17: Continued Commitment Towards Sustainability and ESG
I CONTINUED COMMITMENT TOWARDS SUSTAINABILITY AND ESG Sustainability and ESG initiatives are embedded in our long term growth strategy ENVIRONMENT EMPATHY (E) SOCIAL RESPONSIBILITY (S) CORPORATE GOVERNANCE (G) ➢ Utilize resources efficiently, reduce waste ➢ Total contribution towards CSR activities
Slide 18: Advanced Manufacturing Facilities Designed by In-House Engineering Team
I ADVANCED MANUFACTURING FACILITIES DESIGNED BY IN-HOUSE ENGINEERING TEAM 3 independent functional units at Kurkumbh Industrial Area, Maharashtra with dedicated lines for each product r UNIT 1 NO plant closure notice received from pollution 7 plants control board Total area – 30,000 sq.m __________;
Slide 19: Strong Financial Performance
I STRONG FINANCIAL PERFORMANCE Resilient performance demonstrated over business cycles maintaining a debt free balance sheet REVENUE EBITDA & EBITDA% PAT & PAT% CAGR of 24% EBITDA CAGR of 31% PAT CAGR of 33% 393 419 512 685 936 136 185 259 300 403 98 140 198 229 304 I I I I I I I I I I I I I I I I I
Slide 20: Key Growth Levers
I KEY GROWTH LEVERS Strategic initiatives and investments aimed at long term sustainable growth FOCUS ON ESG AND SIGNIFICANT SUSTAINABILITY GREENFIELD CAPEX Capitalise on our core philosophy Planned capex on track for of clean and green chemistry to commercialising new series of address opportunitie
Slide 21: Thank You
THANK YOU For further information, please contact: PRATIK BORA Email: pratik@cleanscience.co.in Clean Science and Technology Limited Website: https://www.cleanscience.co.in/
Clean Science and Technology — Q2 FY2024 Earnings Presentation on 6ix